two-chambered mcmaster standard slide (CHALEX Corp)
90
Structured Review
CHALEX Corp
two-chambered mcmaster standard slide
Two Chambered Mcmaster Standard Slide, supplied by CHALEX Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/two-chambered+mcmaster+standard+slide/two+chamber+opaque+grid+mcmaster+slide/pm40246158-61-24-27
Average 90 stars, based on 1 article reviews
Two Chambered Mcmaster Standard Slide, supplied by CHALEX Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/two-chambered+mcmaster+standard+slide/two+chamber+opaque+grid+mcmaster+slide/pm40246158-61-24-27
Average 90 stars, based on 1 article reviews
two-chambered mcmaster standard slide - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Homogenization:Article Title: Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine development. Article Snippet: Hookworms infect 450 million people globally and account for the loss of 5 million disability-adjusted life years annually.. Over the last decade, the Human Hookworm Vaccine (HHV) candidate N. americanus Glutathione-S-Transferase-1 (Na-GST-1) has advanced to efficacy testing.. This manuscript describes the manufacture of third-stage N. americanus larvae (NaL3) as an infectious challenge agent to provide “proof-of-concept” for the efficacy of Na-GST-1 prior to more extensive and more resource-intensive vaccine field trials in hookworm endemic areas. Transferring:Article Title: Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine development. Article Snippet: Hookworms infect 450 million people globally and account for the loss of 5 million disability-adjusted life years annually.. Over the last decade, the Human Hookworm Vaccine (HHV) candidate N. americanus Glutathione-S-Transferase-1 (Na-GST-1) has advanced to efficacy testing.. This manuscript describes the manufacture of third-stage N. americanus larvae (NaL3) as an infectious challenge agent to provide “proof-of-concept” for the efficacy of Na-GST-1 prior to more extensive and more resource-intensive vaccine field trials in hookworm endemic areas. |